Stora Enso CEO Jouko Karvinen and the new Stora Enso CEO as

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 21, 2014 at 6:15 AM

Stora Enso CEO Jouko Karvinen and the new Stora Enso CEO as of 1 August Karl-Henrik Sundström comment on the second quarter of 2014 and the short-term priorities

Helsinki, Finland, 2014-07-21 12:01 CEST (GLOBE NEWSWIRE) -- STORA ENSO OYJ STOCK EXCHANGE RELEASE 21 July 2014 at 13.01 EET

Jouko Karvinen, Stora Enso CEO until 31 July 2014, comments:

“The second quarter came out at the high end of our expectations, essentially driven by the better than expected performance of Renewable Packaging and by the Company’s 22% overachievement of the EUR 200 million annual structural cost reduction target. Those achievements combined with the significant improvements in earnings in Printing and Reading and in Building and Living are yet another proof point of the resilience and fighting spirit of the Stora Enso people. As regards Biomaterials, I am happy to see that the ramp-up of Montes del Plata is at, if not beyond, the industry standards.

As this is my last quarterly report after seven years at the helm of the Company, I also want to say a sincere thank you to all our stakeholders for the seven challenging but also rewarding years. So much more remains to be done, but I am confident the same strong interest and support that I have experienced will continue for Stora Enso and its new CEO Karl-Henrik Sundström in transforming Stora Enso into a global renewable materials company.

Finally let me say that I am very happy to hand over the CEO role to Karl-Henrik Sundström. In his two years with the Company he has demonstrated business acumen, strategic thinking and people focus. I am confident that with the great people of Stora Enso, he will do well on the journey to the future.”

Karl-Henrik Sundström, Stora Enso CEO from 1 August 2014:

“I am very honoured to have been trusted to lead Stora Enso. It is exciting to continue on the chosen path and build the future of the Company together with our competent and committed employees. One of my short-term priorities is to build a winning team which can take us forward. Due to the strategic importance of sustainability issues, I will also put more resources into the corporate responsibility area. Currently, I am deepening my knowledge of Stora Enso’s packaging and biomaterials offering, as this business is partly new to me.

Stora Enso’s transformation into a company with increased customer focus goes on. We will continue to deliver value through the Montes del Plata Pulp Mill in Uruguay and our consumer board machine investment in Guangxi, China. The acquisition of the biotechnology company Virdia and the conversion of the Varkaus Mill fine paper machine in Finland to produce virgin-fibre-based containerboard are yet further examples. It is all about winning, together with our customers, today and tomorrow.”

For further information, please contact:
Jouko Karvinen, CEO until 31 July 2014, tel. +358 2046 21410
Karl-Henrik Sundström, CEO as of 1 August 2014, tel. +46 1046 71660

www.storaenso.com
www.storaenso.com/investors

Stora Enso is the global rethinker of the paper, biomaterials, wood products and packaging industry. We always rethink the old and expand to the new to offer our customers innovative solutions based on renewable materials. Stora Enso employs some 29 000 people worldwide, and our sales in 2013 amounted to EUR 10.6 billion. Stora Enso shares are listed on NASDAQ OMX Helsinki (STEAV, STERV) and Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY) in the International OTCQX over-the-counter market.

STORA ENSO OYJ

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

CVS Study: GLP-1 Drugs Effective But Costly

By Hannah Lewis Updated Nov 15, 2026 Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

IDEAYA's IDE101: A New Front in Cancer Battle

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Berry Street Integrates AI with What Matters: Human Touch

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Investors Gear Up for Lennar Class Action Lawsuit

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...